<DOC>
	<DOCNO>NCT02238873</DOCNO>
	<brief_summary>Granulocyte colony stimulate factor ( GCSFs ) stimulate level white blood cell , specifically neutrophil . GCSF support patient receive chemotherapy show decrease rate fever low neutrophil count ( neutropenia ) , cancer type may decrease mortality . Pegfilgrastim pegylated form GCSF name filgrastim . Pegfilgrastim use stimulate bone marrow produce neutrophil fight infection patient undergoing chemotherapy . It much longer half-life parent filgrastim . It remove body within neutrophil . According American Society Clinical Oncology 2006 guideline pegfilgrastim give 24 hour completion chemotherapy i.e.before neutrophil count start drop . Therefore clear neutropenia . Comparative low quality study suggest defer pegfilgrastim delivery neutrophil count start drop may result improved efficacy . This test small randomized control trial ( high quality study , consider `` gold standard '' study ) different setting ( include first chemotherapy lymphoma , solid cancer ) inconsistent result . Pegfilgrastim ( give 24 hour completion chemotherapy ) standard part salvage chemotherapy patient refractory relapse aggressive lymphoma . The investigator plan randomize controlled trial compare efficacy pegfilgrastim give 72 hour ( day +3 ) vs. 24 hour ( day +1 ) completion salvage chemotherapy patient refractory relapse aggressive lymphoma . The investigator evaluate whether change pegfilgrastim schedule affect risk fever neutropenia , neutrophil count , length hospitalization , mortality , safety .</brief_summary>
	<brief_title>Pegfilgrastim Day +3 Compared Day +1 After Salvage Chemotherapy Patients With Refractory Relapsed Aggressive Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<criteria>Adult patient ( age 18 year ) Refractory relapse aggressive lymphoma , include Hodgkin 's nonHodgkin 's lymphoma Candidate salvage chemotherapy . Salvage chemotherapy include one follow regimen : Ifosfamide , etoposide , vincristine ( ICE ) , Cisplatin , cytarabine , dexamethasone ( DHAP ) , Etoposide , methylprednisolone , cytarabine , cisplatin ( ESHAP ) . Chemotherapy dose reduction allow . Chemotherapy without immunotherapy Therapy hospital outpatient clinic Indolent lymphoma ; exclude patient transform lymphoma . Treatment GCSFs primary disease ( e.g . aplastic anemia , MDS ) . Uncontrolled infection Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>lymphoma</keyword>
	<keyword>neutropenia</keyword>
	<keyword>pegfilgrastim</keyword>
</DOC>